Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Christopher Hoyte to Cannabinoids

This is a "connection" page, showing publications Christopher Hoyte has written about Cannabinoids.

 
Connection Strength
 
 
 
0.723
 
  1. Hoyte CO, Jacob J, Monte AA, Al-Jumaan M, Bronstein AC, Heard KJ. A characterization of synthetic cannabinoid exposures reported to the National Poison Data System in 2010. Ann Emerg Med. 2012 Oct; 60(4):435-8.
    View in: PubMed
    Score: 0.359
  2. Brandehoff NP, Baker KA, Bonney CF, Ng PC, Schimmel J, Hoyte CO. Articles You May Have Missed. J Med Toxicol. 2018 06; 14(2):156-159.
    View in: PubMed
    Score: 0.133
  3. Heard K, Marlin MB, Nappe T, Hoyte CO. Common marijuana-related cases encountered in the emergency department. Am J Health Syst Pharm. 2017 Nov 15; 74(22):1904-1908.
    View in: PubMed
    Score: 0.130
  4. Monte AA, Bronstein AC, Cao DJ, Heard KJ, Hoppe JA, Hoyte CO, Iwanicki JL, Lavonas EJ. An outbreak of exposure to a novel synthetic cannabinoid. N Engl J Med. 2014 Jan 23; 370(4):389-90.
    View in: PubMed
    Score: 0.101
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)